| 杭州地区20家医院2004~2006年口服调脂药应用分析 |
| |
| 引用本文： | 杨赞,孙浩珍,沈陶冶. 杭州地区20家医院2004~2006年口服调脂药应用分析[J]. 中国药房, 2008, 19(26): 2016-2018 |
| |
| 作者姓名： | 杨赞 孙浩珍 沈陶冶 |
| |
| 作者单位： | 浙江大学医学院附属第一医院,杭州市,310003 |
| |
| 摘 要： | 目的:了解杭州地区医院口服调脂药的应用情况及变化趋势。方法:对杭州地区20家医院2004~2006年口服调脂药的销售金额和用药频度进行回顾性分析。结果:调脂药总销售金额逐年上升,与2004年相比,2006年增长了47.4%。销售金额和DDDs排序列前几位的主要是阿托伐他汀钙、辛伐他汀、非诺贝特。结论:3-羟基3-甲基戊二酰辅酶A还原酶抑制剂在杭州地区占主导地位。
|
| 关 键 词： | 口服调脂药 用药金额 用药频度 用药分析 |
Analysis of Oral Hypolipidemic Drugs Used in 20 Hospitals in Hangzhou Area from 2004 to 2006 |
| |
| YANG Yun,SUN Hao-zhen,SHEN Tao-ye. Analysis of Oral Hypolipidemic Drugs Used in 20 Hospitals in Hangzhou Area from 2004 to 2006[J]. China Pharmacy, 2008, 19(26): 2016-2018 |
| |
| Authors: | YANG Yun SUN Hao-zhen SHEN Tao-ye |
| |
| Affiliation: | (The First Affiliated Hospital of Medical College of Zhejiang University, Hangzhou 310003, China) |
| |
| Abstract: | OBJECTIVE： To investigate the current application situation and the trend of development of oral hypolipidemic drugs in Hangzhou area. METHODS： The consumption sum and the defined daily dose （DDDs） of the oral anti - hyperlipidemia drugs in 20 hospitals in Hangzhou area during 2004-2006 were analyzed retrospectively. RESULTS： The consumption sum of hypolipidemic drugs increased year by year, up 47.4% in 201）6 as comapred with that in 2004. Atorvastatin calcium, simvastatin and fenofibrate ranked ahead in both consumption sum and DDDs. CONCLUSION： HMG-CoA reductase inhibitors assumed a dominant role among all the hypolipidemic drugs used in Hangzhou area. |
| |
| Keywords: | Oral hypolipidemic drugs Consumption sum DDDs Analysis of drug use |
| 本文献已被 维普 万方数据 等数据库收录！ |
